Fish or shellfish consumption could help patients with AMD

Article

A recent study has revealed that higher consumption of fish or shellfish could help to protect eyes against advanced age-related macular degeneration (AMD).

A recent study has revealed that higher consumption of fish or shellfish could help to protect eyes against advanced age-related macular degeneration (AMD). The data has been published in a recent issue of Ophthalmology.

The research, led by Dr Bonnielin K. Swenor from the Wilmer Eye Institute, Johns Hopkins University, Maryland, USA, explored the relationship between fish and shellfish consumption and AMD status in eyes of participants from the Salisbury Eye Evaluation (SEE) Study.

To estimate the level of weekly fish/shellfish consumption, each patient filled out a food frequency questionnaire. The AMD status was determined from fundus photographs obtained at baseline and graded by 2 masked readers for drusen size, retinal pigment epithelium abnormalities, geographic atrophy (GA) and choroidal neovascularization (CNV). The researchers investigated the association between weekly fish/shellfish consumption and the risk of AMD using logistic regression but adjusted for risk factors and correlation between eyes.

The results demonstrated that there was no difference in the distribution of weekly fish/shellfish consumption between specific AMD categories in comparison with controls. In patients with advanced AMD there was less likelihood of them consuming fish/shellfish that were high in omega-3 fatty acids. Additionally, no relationship was found of AMD with the intake of crab and oysters combined, each of which has high levels of zinc.

From the results the researchers concluded that a protective effect of fish/shellfish intake against advanced AMD was supported.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.